BR9809381A - Composição de vacina anti-helicobacter compreendendo um adjuvante do tipo th1 - Google Patents

Composição de vacina anti-helicobacter compreendendo um adjuvante do tipo th1

Info

Publication number
BR9809381A
BR9809381A BR9809381-9A BR9809381A BR9809381A BR 9809381 A BR9809381 A BR 9809381A BR 9809381 A BR9809381 A BR 9809381A BR 9809381 A BR9809381 A BR 9809381A
Authority
BR
Brazil
Prior art keywords
helicobacter
vaccine composition
type adjuvant
adjuvant
type
Prior art date
Application number
BR9809381-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Jean Haensler
Bruno Guy
Original Assignee
Merieux Oravax
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9705608A external-priority patent/FR2762787B1/fr
Application filed by Merieux Oravax filed Critical Merieux Oravax
Publication of BR9809381A publication Critical patent/BR9809381A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
BR9809381-9A 1997-04-30 1998-04-30 Composição de vacina anti-helicobacter compreendendo um adjuvante do tipo th1 BR9809381A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9705608A FR2762787B1 (fr) 1997-04-30 1997-04-30 Composition vaccinale anti-helicobacter comprenant un adjuvant de type th1
FR9715732 1997-12-08
PCT/FR1998/000875 WO1998048836A1 (fr) 1997-04-30 1998-04-30 Composition vaccinale anti-helicobacter comprenant un adjuvant de type th1

Publications (1)

Publication Number Publication Date
BR9809381A true BR9809381A (pt) 2000-07-04

Family

ID=26233513

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809381-9A BR9809381A (pt) 1997-04-30 1998-04-30 Composição de vacina anti-helicobacter compreendendo um adjuvante do tipo th1

Country Status (7)

Country Link
EP (1) EP0979100A1 (fr)
JP (1) JP2002505665A (fr)
KR (1) KR20010020418A (fr)
AU (1) AU750379B2 (fr)
BR (1) BR9809381A (fr)
CA (1) CA2287976A1 (fr)
WO (1) WO1998048836A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2781160B1 (fr) * 1998-07-03 2000-08-18 Pasteur Merieux Serums Vacc Utilisation d'un compose amphipathique pour adjuver un vaccin sous-unitaire
EP1229925A2 (fr) * 1999-11-19 2002-08-14 Axxima Pharmaceuticals Aktiengesellschaft Inhibiteurs de maladies gastro-intestinales induites par helicobacter pilori
GB0008877D0 (en) * 2000-04-12 2000-05-31 Astrazeneca Ab Polypeptide delivery system
GB0008879D0 (en) * 2000-04-12 2000-05-31 Astrazeneca Ab Polypeptide delivery system
WO2002005845A1 (fr) * 2000-07-05 2002-01-24 Merieux Oravax Combinaisons immunologiques pour la prophylaxie et la therapie d'une infection par helicobacter pylori
US6849409B2 (en) 2000-10-16 2005-02-01 Axxima Pharmaceuticals Ag Cellular kinases involved in Cytomegalovirus infection and their inhibition
JP2004528321A (ja) * 2001-04-04 2004-09-16 ノルディック ワクチン テクノロジー アクティーゼルスカブ ステロールおよびサポニンを含むポリヌクレオチド結合複合体
JP2012171914A (ja) * 2011-02-22 2012-09-10 Kao Corp Ｇｉｐ上昇抑制剤
RU2736642C2 (ru) * 2015-07-20 2020-11-19 Зоэтис Сервисиз Ллс Липосомальные адъювантные композиции
US10456459B2 (en) * 2015-07-20 2019-10-29 Zoetis Services Llc Liposomal adjuvant compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3521994A1 (de) * 1985-06-20 1987-01-02 Bayer Ag N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
CA1331443C (fr) * 1987-05-29 1994-08-16 Charlotte A. Kensil Adjuvant a saponine
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection
FR2732605B1 (fr) * 1995-04-07 1997-05-16 Pasteur Merieux Serums Vacc Composition destinee a l'induction d'une reponse immunitaire mucosale

Also Published As

Publication number Publication date
AU7658498A (en) 1998-11-24
AU750379B2 (en) 2002-07-18
WO1998048836A1 (fr) 1998-11-05
CA2287976A1 (fr) 1998-11-05
EP0979100A1 (fr) 2000-02-16
JP2002505665A (ja) 2002-02-19
KR20010020418A (ko) 2001-03-15

Similar Documents

Publication Publication Date Title
BRPI9609414B8 (pt) combinação de vacina e kit para produzir a mesma.
BR9915988A (pt) Vacina para peptidase c5a estreptocócica
BR9809381A (pt) Composição de vacina anti-helicobacter compreendendo um adjuvante do tipo th1
NO20005051L (no) Adjuvantsammensetninger
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
ES2195169T3 (es) Vacunas contra calmidias y composiciones inmunogenicas que contienen un antigeno de membrana externa y metodos para su preparacion.
BR0014285A (pt) Adjuvantes compreendendo um éster ou éter de alquila de polioxietileno e pelo menos um tensoativo não-iÈnico
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
UA40597C2 (uk) Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
ATE116993T1 (de) Saponin-hilfsmittel.
BR9714082A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto.
BRPI0007936B8 (pt) composto, formulação adjuvante imunológica, e formulação de vacina.
NO20082472L (no) Vaksinesammensetninger omfattende en saponin adjuvant
DE69818707D1 (de) Chitosan und influenza-antigen(e) enthaltende impfstoff-zubereitungen zur verabreichung durch eine mukosa
HUP0301180A2 (hu) Imidazokinolinaminok adjuvánsként való használata DNS vakcinálásban
WO2005116270A3 (fr) Composition de vaccin contre le virus de la grippe et ses methodes d'utilisation
BR0213358A (pt) Uso de flibanserina
BR0108828A (pt) Formulação de carboidrato (adjuvante pré-biótico) para aperfeiçoamento de resposta imuno
AR034900A1 (es) Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica
BR0114392A (pt) Formulação de vacina, método para produzir uma formulação de vacina, uso de uma preparação de vacina contra rsv dividido, kit para liberação de uma formulação de vacina intranasal, dispositivo de liberação intranasal, e, método para proteger ou tratar um mamìfero susceptìvel a, ou sofrendo de doença causada por rsv
UY24654A1 (es) Composición de vacuna contra la malaria
BR112023002932A2 (pt) Vetores de adenovírus e métodos para uso de vetores de adenovírus
PT854924E (pt) Antigenios de leishmania para uso na terapia e diagnostico da leishmaniose
BR0316244A (pt) Vacina de polinucleotìdeo, métodos de prevenção ou de tratamento de uma infecção por hcv em um mamìfero e de vacinação de um indivìduo, e, uso de uma vacina de polinucleotìdeo
BRPI0416376A (pt) composições para a redução da colonização bacteriana e da invasão do snc e métodos de uso destes

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADE(S)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1912 DE 28/08/2007.